Potential of general practice data for congenital anomaly research: Comparison with registry data in the united kingdom

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 97, Issue 8, 2013, Pages 546-553

  Sokal, Rachel ^a   Fleming, Kate M ^a   Tata, Laila J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Congenital anomalies; Epidemiology; EUROCAT; Prevalence; Primary care data

Indexed keywords

ABDOMINAL WALL DEFECT; ARTICLE; CHILD; CHROMOSOME ABERRATION; CLEFT PALATE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DISEASE CLASSIFICATION; DISEASE REGISTRY; DISEASE SURVEILLANCE; EAR MALFORMATION; EYE MALFORMATION; FACE MALFORMATION; FOLLOW UP; GASTROINTESTINAL MALFORMATION; GENERAL PRACTICE; GENITAL MALFORMATION; HUMAN; LIMB MALFORMATION; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; NECK MALFORMATION; NERVOUS SYSTEM MALFORMATION; POPULATION AND POPULATION RELATED PHENOMENA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT MALFORMATION; RISK ASSESSMENT; SCHOOL CHILD; SKELETON MALFORMATION; TERATOGENESIS; UNITED KINGDOM; UROGENITAL TRACT MALFORMATION;

CONGENITAL ANOMALIES; EPIDEMIOLOGY; EUROCAT; PREVALENCE; PRIMARY CARE DATA;

CONGENITAL ABNORMALITIES; FETAL DEATH; GENERAL PRACTICE; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; POPULATION SURVEILLANCE; REGISTRIES;

EID: 84881662066     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23150     Document Type: Article

References (33)

1. Armstrong BG, Dolk H, Pattenden S, et al. 2007. Geographic variation and localised clustering of congenital anomalies in Great Britain. Emerg Themes Epidemiol 4:14.
2. Axt-Fliedner R, Schwarze A, Smrcek J, et al. 2006. Isolated ventricular septal defects detected by color Doppler imaging: evolution during fetal and first year of postnatal life. Ultrasound Obstet Gynecol 27:266-273.
3. BINOCAR. 2012. Congenital anomaly statistics 2010 England and Wales. Available at: http://www.binocar.org/content/Annual%20report%202010%20FINAL%2031_07_12%20v2.pdf. Accessed March 12, 2013.
4. Bower C, Rudy E, Callaghan A, Quick J, Nassar N. 2010. Age at diagnosis of birth defects. Birth Defects Res A Clin Mol Teratol 88:251-255.
5. Boyd PA, Armstrong B, Dolk H, et al. 2005. Congenital anomaly surveillance in England-ascertainment deficiencies in the national system. BMJ 330:27.
6. Boyd PA, Haeusler M, Barisic I, et al. 2011. Paper 1: the EUROCAT network-organization and processes. Birth Defects Res A Clin Mol Teratol 91(Suppl 1):S2-S15.
7. Centre for Maternal and Child Enquiries. 2011. Perinatal mortality 2009. Available at: http://www.hqip.org.uk/assets/NCAPOP-Library/CMACE-Reports/35.-March-2011-Perinatal-Mortality-2009.pdf. Accessed April 10, 2013.
8. Charlton RA, Cunnington MC, de Vries CS, Weil JG. 2008. Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries. Drug Saf 31:39-51.
9. Charlton RA, Weil JG, Cunnington MC, de Vries CS. 2010. Identifying major congenital malformations in the UK General Practice Research Database (GPRD): A study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD. Drug Saf 33:741-750.
10. Department of Health. 2011. Abortion statistics, England and Wales, 2010. Available at: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsStatistics/DH_126769. Accessed June 21, 2012.
11. Devine S, West SL, Andrews E, et al. 2008. Validation of neural tube defects in the full featured-general practice research database. Pharmacoepidemiol Drug Saf. 17:434-444.
12. Devlin L, Morrison PJ. 2004. Accuracy of the clinical diagnosis of Down syndrome. Ulster Med J 73:4-12.
13. Dolk H, EUROCAT Project Team. 2003. A study of the geographical variation in overall rates of congenital abnormalities and the rates of specific abnormalities.
14. EUROCAT. 2005. Minor anomalies for exclusion. Available at: http://www.eurocat-network.eu/content/EUROCAT-Guide-1.3-Chapter-3.2.pdf. Accessed April 12, 2012.
15. EUROCAT. 2008. Coding of EUROCAT Subgroups of Congenital Anomalies. Available at: http://www.eurocat-network.eu/content/EUROCAT-Guide-1.3-Chapter-3.3.pdf. Accessed April 12, 2012.
16. EUROCAT. 2010a. EUROCAT. Available at: http://www.eurocat-network.eu/. Accessed December 22, 2010.
17. EUROCAT. 2010b. Prevalence data tables. Available at: http://www.eurocat-network.eu/ACCESSPREVALENCEDATA/PrevalenceTables. Accessed January 26, 2012.
18. Garne E, Loane M, Dolk H, et al. 2012. Spectrum of congenital anomalies in pregnancies with pregestational diabetes. Birth Defects Res A Clin Mol Teratol 94:134-140.
19. Greenlees R, Neville A, Addor MC, et al. 2011. Paper 6: EUROCAT member registries: Organization and activities. Birth Defects Res A Clin Mol Teratol 91(Suppl 1):S51-S100.
20. Greenlees R, Garne E. 2008. Congenital anomalies diagnosed after age 1 year and their impact on prevalence. Available at: http://www.eurocat-network.eu/content/EUROCAT-Short-Report-Cases-Diagnosed-After-1-Year.pdf. Accessed May 31, 2012.
21. Kendle International Inc. 2012. The antiretroviral pregnancy registry. Available at: http://www.apregistry.com/. Accessed February 20, 2013.
22. Khoury MJ, Flanders WD, James LM, Erickson JD. 1989. Human teratogens, prenatal mortality, and selection bias. Am J Epidemiol 130:361-370.
23. Loane M, Dolk H, Garne E, et al. 2011. Paper 3: EUROCAT data quality indicators for population-based registries of congenital anomalies. Birth Defects Res A Clin Mol Teratol 91(Suppl 1):S23-S30.
24. Meijer WM, Cornel MC, Dolk H, et al. 2006. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study. Pharmacoepidemiol Drug Saf 15:675-682.
25. Neeli S, Nerli R. 2010. Re: Harry Fisch et al.: Rising hypospadia rates: disproving a myth. (J Pediatr Urol 2010;6:37-39). J Pediatr Urol 6:528.
26. Nelson P, Nieuwenhuijsen M, Jensen TK, et al. 2007. Prevalence of hypospadias in the same geographic region as ascertained by three different registries. Birth Defects Res A Clin Mol Teratol 79:685-687.
27. Rankin J, Pattenden S, Abramsky L, et al. 2005. Prevalence of congenital anomalies in five British regions, 1991-99. Arch Dis Child Fetal Neonatal Ed 90:F374-F379.
28. Savva GM, Morris JK. 2009. Ascertainment and accuracy of Down syndrome cases reported in congenital anomaly registers in England and Wales. Arch Dis Child Fetal Neonatal Ed 94:F23-F27.
29. Scheuerle A, Vannappagari VX, Miller MK., 2009. Measurements of birth defect prevalence: Which is most useful as a comparator group for pharmaceutical pregnancy registries? Birth Defects Res A Clin Mol Teratol 85:611-620.
30. Shipman SA, Helfand M, Moyer VA, Yawn BP. 2006. Screening for developmental dysplasia of the hip: a systematic literature review for the US Preventive Services Task Force. Pediatrics 117:e557-e576.
31. Wurst KE, Ephross SA, Loehr J, et al. 2007a. Evaluation of the general practice research database congenital heart defects prevalence: comparison to United Kingdom national systems. Birth Defects Res A Clin Mol Teratol 79:309-316.
32. Wurst KE, Ephross SA, Loehr J, et al. 2007b. The utility of the general practice research database to examine selected congenital heart defects: a validation study. Pharmacoepidemiol Drug Saf 16:867-877.
33. Yates R, Cook L. 2001. Chapter 8: geographical variation in congenital anomaly notifications in England and Wales. In: Griffiths C, Fitzpatrick J, & Office for National Statistics, editors. Geographic variations in health. London: Stationery Office. Available at: http://www.ons.gov.uk/ons/rel/subnational-health3/geographic-variations-in-health-ds-no-16-/2001/chapter-8.pdf. Accessed June 13, 2012.